United States · FDA National Drug Code directory
Exelon
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0502_9b5555ca-d9a2-4f50-8037-abbf702d0a27
- Product NDC
- 0078-0502
- Form
- PATCH, EXTENDED RELEASE
- Composition / generic term
- rivastigmine
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20070706 / 20261231
Source-listed ingredients
- RIVASTIGMINE — 9.5 mg/24h
These values do not establish equivalence or a dose recommendation.
Packages
- 30 PATCH in 1 CARTON (0078-0502-15) / 24 h in 1 PATCH (0078-0502-61) · 0078-0502-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →